Move LeftMove Right
Research

Our cancer research

Researchers in Sanford-Burnham’s NCI-designated Cancer Center study normal cellular processes and what causes them to go awry. They are interested in understanding how cancer cells fail to repair damaged DNA, reproduce without restraint, form tumors, colonize other tissues in the body and ignore signals telling them to stop proliferating and start self-destructing.

The impact on your health

Cancer Center scientists have created two FDA-approved cancer drugs and five experimental therapies currently in clinical trials. These include targeting technologies that deliver drugs specifically to a tumor and drugs that trick cancer cells into committing suicide. Clinical trials are also underway to test a technique that uses stem cells to deliver chemotherapeutics to brain tumors. Read More

Children's Health

Understanding children's health

Researchers in Sanford Children’s Health Research Center are working to uncover the molecular basis of several rare, inherited genetic diseases. Others study type 1 diabetes or cardiac and skeletal muscle disorders. Our scientists are also pioneering microRNA-based techniques to study and treat human disease.

Promising treatments

Sanford-Burnham researchers have helped develop the first treatments for several rare diseases affecting children, such as hypophosphatasia and congenital disorders of glycosylation. Scientists in this center have also created a protective coating for the insulin-producing cells that are destroyed by the immune system in type 1 diabetes. Read More

Diabetes & Obesity

Diabetes and obesity

Researchers in the Diabetes and Obesity Center, located in Lake Nona, Orlando, are investigating the pathophysiology of common metabolic diseases (such as obesity) and the cardiovascular complications they cause. This multi-disciplinary group studies the control of metabolism, including the complex interactions between cells and organs that influence caloric intake and energy balance.

Improving human health

Researchers in this center have teamed up with Florida Hospital, the Translational Research Institute for Metabolism and Diabetes, and a major pharmaceutical company to identify obesity-related biomarkers and other targets with therapeutic potential. Read More

Infectious & Inflammatory Diseases

Infection and inflammation

Researchers in the Infectious and Inflammatory Disease Center study the relationship between the human body and the bacteria that live within it. They take a system-wide appreciation of what’s happening in a cell or organism and develop the computing and organizational power to make sense of it all.

Improving human health

Scientists in this center study the cells responsible for inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases, and discovered a human gene variant that prompts the immune system to attack insulin-producing cells, causing type 1 diabetes. Read More

Neuroscience
& Aging

Neuroscience and aging

Neuroscience may be the yin to cancer’s yang. If we can learn how to kill treatment-resistant cancer cells, we can learn how to protect cells in the brain. Neurodegenerative diseases, such as Alzheimer's, and cancer, are both diseases of aging. Scientists at Sanford-Burnham are advancing the understanding of degenerative diseases, as well as the processes of normal aging.

Improving human health

Discoveries made by scientists in the Center have paved the way for development of a drug for Alzheimer's that, for the first time, gets to the root of the problem, possibly preventing brain cell death rather than merely masking symptoms caused by loss of these cells. Numerous other strategies are being developed for either protecting cells or replacing cells lost due to degenerative diseases of the brain and other organs. Read More

Translational Research

From the lab bench

The Translational Research Institute for Metabolism and Diabetes serves as a bridge between basic discovery research and patient-oriented research. It binds the strengths of Florida Hospital’s large patient base and clinical research expertise with Sanford-Burnham’s basic science and advanced research technologies in metabolomics, genomics and proteomics.

To the bedside

The TRI is expected to hasten the discovery and development of new approaches to diagnose, prevent, and treat diabetes, obesity and their cardiovascular complications. One key aim is to produce unique insights into the sub-classifications of diabetes, thus promoting the advent of personalized disease therapies. Read More

Stem Cells  & Regenerative Medicine

Stem cell research

The Center for Stem Cell Biology and Regenerative Medicine approaches disease from the perspective that degeneration, malformations, and cancer are abnormalities in biological development and homeostasis. The Center explores therapies that invoke and harness developmental processes, such as cell repair mechanisms, protection, molecular and cellular manipulation, and drugs that drive direct these processes.

Stem cell promise

Stem cells are distinguished by their ability to differentiate into many types of cells in the body and to self-replicate indefinitely. Their very nature has intrigued scientists who foresee a day when stem cells could be used to replace diseased and injured tissue in patients, to screen and test new drugs, and to learn more about our fundamental biology. Read More

Shared Resources

Shared resources

The Institute provides scientists with access to state-of-the-art instrumentation through a network of over 30 technology cores. This infrastructure supports scientists with advanced technologies that otherwise would be impossible for one lab to afford. Shared Resources also offers investigators the expertise to help design and interpret their experiments and if desired, train their lab staff to self-operate the advanced equipment.

An infrastructure for success

Scientists have used advanced technologies to empower their research and accelerate their discoveries. Investigators use metabolomics to profile patient samples to gain insight about how diseases develop differently between individuals. Other technologies such as genomics and proteomics aid in identifying new biomarkers that may allow for more precise and earlier diagnosis. Read More

Nanomedicine

Turning an innovation...

The Office of Technology Management and Commercialization helps bring biomedical research innovations to the marketplace as new therapies. Our business development team is also actively engaged in developing relationships with potential partners and funding organizations for the advancement of shared research initiatives.

…into a life-saving product

Since the Institute’s founding in 1976, our research has led to more than 600 patents and 90 license agreements with strategic partners. We are proud to partner with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (a division of Johnson & Johnson), Pfizer, and Takeda to advance our discoveries to the clinical research stage more quickly. Read More

Chemical Genomics

Chemical genomics

Where do new medicines come from? Sanford-Burnham is part of an NIH effort to bridge the gap between basic research carried out in academic research laboratories and FDA approval of new medicines. The Conrad Prebys Center for Chemical Genomics (CPCCG) at Sanford-Burnham screens chemical compounds by the millions to find the few that could potentially be developed into new medicines.

Drug discovery

In the past, most new drugs and therapies came from the laboratories of pharmaceutical companies. In a major shift, the early discovery work is moving into academic research labs with strong collaborative ties to industry. Sanford-Burnham is working with Johnson & Johnson, Pfizer and Takeda Pharmaceuticals among others to get new drugs into the pipeline for the diseases where the need is greatest. Read More

  • Research
  • Cancer
  • Children's Health
  • Diabetes & Obesity
  • Infectious &
    Inflammatory Diseases
  • Neuroscience
    & Aging
  • Chemical Genomics
       & Drug Discovery
  • Commercialization
  • Shared Resources
  • Stem Cells &
    Regenerative Medicine
  • Translational Research
  • Technology
Home: Slide Show
Visit Our Science Blog

Sanford-Burnham

Science News

View All

Sanford-Burnham

Paper of the Week

Sign In Skip Navigation Links Skip navigation links
Our Mission
Research
Talent
Technology
Training & Education
Our Supporters
Privacy Policy
Skip navigation links
Our Mission
Sanford-Burnham-at-a-Glance
About Our Science
Our Locations
Contact
Research
Programs
Centers
Your Health
Talent
Find a Scientist
Leadership
Technology
Technology Centers
Shared Resources
Office of Technology Management and Commercialization
Training & Education
Postdoctoral Training
Graduate School of Biomedical Sciences
Office of Training and Academic Services
Our Supporters
Make an Online Donation
How to Support
Portal
Events
Memorials and Tributes
Support a Project
The Fishman Fund
President's Circle
Contact External Relations
Campus Tours
Login / Create New Account
Privacy Policy